Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

Historical Holders from Q2 2022 to Q1 2025

Symbol
CLRB on Nasdaq
CUSIP
15117F807
Type / Class
Equity / Common stock, par value $0.00001
Shares outstanding
43.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
5.1M
Holdings value
$1.53M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
31
Number of buys
15
Number of sells
-15
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LYTTON LAURENCE W 8.8% $1.31M 3.96M LYTTON LAURENCE W Dec 31, 2024
Nantahala Capital Management, LLC 5.73% -42.6% $827K -$386K 2.51M -31.8% Nantahala Capital Management, LLC Dec 31, 2024
HIRSCHMAN ORIN 4.9% $667K 2.02M Orin Hirschman Dec 31, 2024

Institutional Holders of Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 0 $0 -$299 0
2024 Q4 5.1M $1.53M -$20.7M $0.30 31
2024 Q3 14M $30M +$5.03M $2.14 34
2024 Q2 11.6M $28.3M +$5.52M $2.50 37
2024 Q1 9.13M $36.3M +$2.82M $3.98 45
2023 Q4 8.58M $23.8M +$10.4M $2.77 25
2023 Q3 1.46M $3.85M -$265K $2.64 20
2023 Q2 1.58M $3.08M -$218K $1.95 18
2023 Q1 1.69M $2.43M -$324K $1.43 18
2022 Q4 1.88M $3.22M +$2.15M $1.71 23
2022 Q3 636K $2.14M +$2.12M $3.36 18
2022 Q2 56K $23K +$23K $0.41 1